PROTEIN I Trademark

Trademark Overview

On Friday, December 4, 2015, a trademark application was filed for PROTEIN I with the United States Patent and Trademark Office. The USPTO has given the PROTEIN I trademark a serial number of 86839776. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, June 21, 2023. This trademark is owned by PhoreMost Limited. The PROTEIN I trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research for medical purposes in the field of cancerous diseases; providing scientific and pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals for the alleviation, diagnosis, prevention and treatment of disease and medical conditions; research and development services in connection with finding and developing new pharmaceutical products for others to put on the market; providing research services in the field of cancer and cancer prevention; providing phenotypic screening, namely, screenings that feature technology that enables targeted screening for systematic identification and access to intracellular druggable sites for scientific and pharmaceutical research and drug discovery purposes; providing information, advisory and consultancy services in relation to the aforesaid services
protein i

General Information

Serial Number86839776
Word MarkPROTEIN I
Filing DateFriday, December 4, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, June 21, 2023
Registration Number5174215
Registration DateTuesday, April 4, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 15, 2016

Trademark Statements

Disclaimer with Predetermined Text"PROTEIN"
Goods and ServicesScientific research for medical purposes in the field of cancerous diseases; providing scientific and pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals for the alleviation, diagnosis, prevention and treatment of disease and medical conditions; research and development services in connection with finding and developing new pharmaceutical products for others to put on the market; providing research services in the field of cancer and cancer prevention; providing phenotypic screening, namely, screenings that feature technology that enables targeted screening for systematic identification and access to intracellular druggable sites for scientific and pharmaceutical research and drug discovery purposes; providing information, advisory and consultancy services in relation to the aforesaid services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 9, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePhoreMost Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressPampisford CB223FT
GB
Party NamePhoreMost Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCambridge CB23 8DS
GB
Party NamePhoreMost Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCambridge CB23 8DS
GB

Trademark Events

Event DateEvent Description
Wednesday, June 21, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, June 21, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, June 20, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 20, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, April 4, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, February 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, February 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, January 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, January 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 1, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, March 1, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 1, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 1, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 4, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, March 1, 20171(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, February 15, 2017NOTICE OF ALLOWANCE CANCELLED
Monday, February 27, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, February 15, 2017TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, January 10, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 15, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2016PUBLISHED FOR OPPOSITION
Wednesday, October 26, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 11, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, September 28, 2016LETTER OF SUSPENSION E-MAILED
Wednesday, September 28, 2016SUSPENSION LETTER WRITTEN
Wednesday, September 28, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 28, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, September 23, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 23, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 23, 2016NON-FINAL ACTION E-MAILED
Wednesday, March 23, 2016NON-FINAL ACTION WRITTEN
Wednesday, March 23, 2016ASSIGNED TO EXAMINER
Friday, March 4, 2016PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Friday, February 26, 2016ASSIGNED TO LIE
Thursday, February 18, 2016TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, December 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 8, 2015NEW APPLICATION ENTERED

Related Keywords

protein research providing services scientific pharmaceutical field medical screening information cancer